ARTERIOVENOUS FISTULA SITE INFECTION

This adverse event was reported 135 times

ARTERIOVENOUS FISTULA SITE INFECTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID 1 0.0016
1 SODIUM POLYSTYRENE SULFONATE 2 0.0013
2 PARICALCITOL 14 0.0010
3 SEVELAMER CARBONATE 7 0.0006
4 CALCIUM ACETATE 3 0.0006
5 EPOETIN ALFA 6 0.0005
6 DARBEPOETIN ALFA 25 0.0005
7 BELATACEPT 2 0.0004
8 CICLOPIROX 1 0.0004
9 VANCOMYCIN HYDROCHLORIDE 3 0.0004
See all drugs enriched for association with ARTERIOVENOUS FISTULA SITE INFECTION

ARTERIOVENOUS FISTULA SITE INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Vitamin D2 Analog [EPC] 14 0.0020
1 Vitamin D Analog [EPC] 14 0.0008
2 Skin Test Antigen [EPC] 1 0.0005
3 Erythropoiesis-stimulating Agent [EPC] 25 0.0005
4 Selective T Cell Costimulation Blocker [EPC] 2 0.0004
5 Phosphate Binder [EPC] 1 0.0003
6 Uric Acid-specific Enzyme [EPC] 1 0.0003
7 Potassium Binder [EPC] 3 0.0002
8 Provitamin D2 Compound [EPC] 5 0.0002
9 GLP-2 Analog [EPC] 2 0.0001
See all drug classes enriched for association with ARTERIOVENOUS FISTULA SITE INFECTION